An Enteropathy-like Indolent NK-Cell Proliferation Presenting in the Female Genital Tract.
Journal
The American journal of surgical pathology
ISSN: 1532-0979
Titre abrégé: Am J Surg Pathol
Pays: United States
ID NLM: 7707904
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
pubmed:
15
10
2019
medline:
29
7
2020
entrez:
15
10
2019
Statut:
ppublish
Résumé
Natural killer (NK) cell enteropathy is a lymphoproliferative disorder, initially described by Mansoor and colleagues, that presents in the gastrointestinal tract, and is often mistaken for extranodal NK/T-cell lymphoma on first assessment. This population of cells in this process have an NK-cell phenotype (CD3, CD56, CD2, CD7), lacks evidence of Epstein-Barr virus infection, has germline rearrangement of the T-cell receptor, and a very indolent clinical course. Indeed, many of such patients had been originally diagnosed as having an NK/T-cell lymphoma, and subsequently received chemotherapy. We report a unique case where an indolent lymphoproliferative disorder with features that resemble NK-cell enteropathy is encountered for the first time outside the gastrointestinal tract, specifically in the female genitourinary tract. We provide morphologic, immunophenotypic, and molecular documentation of such, in association with a completely indolent clinical behavior of this type of process.
Identifiants
pubmed: 31609783
doi: 10.1097/PAS.0000000000001387
pmc: PMC7071997
mid: NIHMS1540166
pii: 00000478-202004000-00015
doi:
Substances chimiques
Genetic Markers
0
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
561-565Subventions
Organisme : Intramural NIH HHS
ID : Z01 BC010676-03
Pays : United States
Organisme : Intramural NIH HHS
ID : Z01 BC010684-03
Pays : United States
Organisme : Intramural NIH HHS
ID : Z01 BC011070
Pays : United States
Références
Am J Pathol. 2017 May;187(5):980-986
pubmed: 28284718
Blood. 2009 Apr 23;113(17):3931-7
pubmed: 19029440
Gynecol Obstet Invest. 2006;61(3):164-6
pubmed: 16424671
Pathol Int. 2014 Jun;64(6):263-6
pubmed: 24965108
Pathology. 2018 Dec;50(7):718-724
pubmed: 30348505
Blood. 2011 Feb 3;117(5):1438-9
pubmed: 21292781
Semin Diagn Pathol. 2017 Jan;34(1):60-75
pubmed: 27988064
Am J Surg Pathol. 2006 Apr;30(4):539-44
pubmed: 16625103
Hum Pathol. 2018 Sep;79:18-41
pubmed: 29885408
Am J Clin Pathol. 2019 Jan 1;151(1):75-85
pubmed: 30212873
Br J Dermatol. 2007 Mar;156(3):560-2
pubmed: 17300249
Pathology. 2019 Apr;51(3):338-340
pubmed: 30819538
Mod Pathol. 2003 Feb;16(2):166-72
pubmed: 12591970
Diagn Pathol. 2014 May 23;9:95
pubmed: 24886075
Leuk Lymphoma. 2019 Jul;60(7):1626-1631
pubmed: 30997845
Am J Surg Pathol. 1996 Jan;20(1):103-11
pubmed: 8540601
Oncotarget. 2015 Jul 10;6(19):17764-76
pubmed: 25980440
Clin Lymphoma Myeloma Leuk. 2018 Jul;18(7):e279-e281
pubmed: 29752211
Leukemia. 2014 Feb;28(2):338-48
pubmed: 23689514
Blood. 2011 Feb 3;117(5):1447-52
pubmed: 20966166
Blood. 2010 Dec 16;116(25):5631-7
pubmed: 20829373
Korean J Pathol. 2014 Feb;48(1):73-6
pubmed: 24627701
Blood Adv. 2018 Jul 10;2(13):1616-1627
pubmed: 29986854
Haematologica. 2014 Sep;99(9):1421-32
pubmed: 25176983
Blood. 2019 Sep 19;134(12):986-991
pubmed: 31383643
Front Pediatr. 2019 Mar 15;7:71
pubmed: 30931288
Discov Med. 2017 Mar;23(126):189-199
pubmed: 28472613
Diagn Cytopathol. 2016 May;44(5):430-3
pubmed: 26872300
Am J Surg Pathol. 2012 Nov;36(11):1656-65
pubmed: 23073324